SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 131 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,456 | -98.4% | 3,600 | -97.8% | 0.00% | – |
Q1 2022 | $210,000 | -60.2% | 162,991 | -60.7% | 0.00% | -100.0% |
Q4 2021 | $527,000 | -40.2% | 414,797 | +2.5% | 0.00% | 0.0% |
Q3 2021 | $882,000 | -47.8% | 404,538 | -10.2% | 0.00% | -50.0% |
Q2 2021 | $1,690,000 | +2.9% | 450,550 | -10.6% | 0.00% | 0.0% |
Q1 2021 | $1,643,000 | -2.1% | 503,919 | +2.3% | 0.00% | 0.0% |
Q4 2020 | $1,679,000 | -3.7% | 492,479 | +15.3% | 0.00% | -33.3% |
Q3 2020 | $1,743,000 | +33.6% | 427,223 | +10.7% | 0.00% | +50.0% |
Q2 2020 | $1,305,000 | +48.1% | 385,979 | +2.1% | 0.00% | 0.0% |
Q1 2020 | $881,000 | -32.7% | 378,019 | +5.1% | 0.00% | 0.0% |
Q4 2019 | $1,309,000 | -53.0% | 359,681 | +7.1% | 0.00% | -60.0% |
Q3 2019 | $2,787,000 | +1.9% | 335,955 | +5.7% | 0.01% | 0.0% |
Q2 2019 | $2,735,000 | -13.4% | 317,691 | +7.5% | 0.01% | -16.7% |
Q1 2019 | $3,160,000 | +24.7% | 295,596 | +2.0% | 0.01% | 0.0% |
Q4 2018 | $2,535,000 | -35.3% | 289,725 | +24.2% | 0.01% | -25.0% |
Q3 2018 | $3,919,000 | -19.0% | 233,254 | +1.0% | 0.01% | -20.0% |
Q2 2018 | $4,839,000 | +38.5% | 230,884 | +6.4% | 0.01% | +42.9% |
Q1 2018 | $3,493,000 | -12.5% | 217,072 | +3.1% | 0.01% | -12.5% |
Q4 2017 | $3,992,000 | +73.1% | 210,642 | +28.5% | 0.01% | +60.0% |
Q3 2017 | $2,306,000 | +97.9% | 163,884 | +4.8% | 0.01% | +66.7% |
Q2 2017 | $1,165,000 | +19.0% | 156,334 | +3.8% | 0.00% | +50.0% |
Q1 2017 | $979,000 | +101.4% | 150,580 | +37.4% | 0.00% | +100.0% |
Q4 2016 | $486,000 | -5.1% | 109,596 | +0.0% | 0.00% | 0.0% |
Q3 2016 | $512,000 | -19.7% | 109,584 | +12.8% | 0.00% | -50.0% |
Q2 2016 | $638,000 | -11.0% | 97,129 | -13.8% | 0.00% | 0.0% |
Q1 2016 | $717,000 | +13.4% | 112,685 | +7.6% | 0.00% | 0.0% |
Q4 2015 | $632,000 | +7.5% | 104,755 | +6.5% | 0.00% | 0.0% |
Q3 2015 | $588,000 | -7.3% | 98,355 | +6.2% | 0.00% | 0.0% |
Q2 2015 | $634,000 | +3.3% | 92,645 | -8.4% | 0.00% | 0.0% |
Q1 2015 | $614,000 | -6.3% | 101,125 | +6.9% | 0.00% | 0.0% |
Q4 2014 | $655,000 | -8.8% | 94,575 | +7.2% | 0.00% | 0.0% |
Q3 2014 | $718,000 | +0.7% | 88,250 | +0.6% | 0.00% | 0.0% |
Q2 2014 | $713,000 | 0.0% | 87,750 | -3.5% | 0.00% | 0.0% |
Q1 2014 | $713,000 | -13.9% | 90,944 | -2.8% | 0.00% | 0.0% |
Q4 2013 | $828,000 | -1.4% | 93,564 | -6.5% | 0.00% | -33.3% |
Q3 2013 | $840,000 | +14.0% | 100,114 | +1.4% | 0.00% | +50.0% |
Q2 2013 | $737,000 | – | 98,769 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |